Literature DB >> 3015635

Protoporphyrinogen oxidase and porphobilinogen deaminase in variegate porphyria.

P N Meissner, R S Day, M R Moore, P B Disler, E Harley.   

Abstract

Two enzymes of the haem biosynthetic pathway were investigated in patients with variegate porphyria. Protoporphyrinogen oxidase in cultures of Epstein-Barr virus transformed lymphoblasts from twenty-seven patients showed a mean maximal velocity (Vmax) of 0.39 +/- 0.08+ nmol of protoporphyrin mg protein-1 h-1, a 52% reduction (P less than 0.001) from a non-porphyric control group (0.82 +/- 0.10). Km values (1.00 +/- 0.27 microM) did not differ significantly (P greater than 0.05) from control values in any of the patients. The mean Vmax of porphobilinogen deaminase in the cultures was 1.50 +/- 0.18 nmol of uroporphyrin mg protein-1 min-1, a 24% reduction (P less than 0.001) from controls (1.94 +/- 0.14). Mean porphobilinogen deaminase activity in the erythrocytes of twenty-one patients with variegate porphyria was 8.37 +/- 1.99 nmol of uroporphyrin 1 erythrocytes-1 s-1, a 28% reduction (P less than 0.001) from normal (11.98 +/- 2.11). The reduced activities of these two enzymes comply with the expression of variegate porphyria during its quiescent and acute phases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015635     DOI: 10.1111/j.1365-2362.1986.tb01339.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Crystal structure of protoporphyrinogen oxidase from Myxococcus xanthus and its complex with the inhibitor acifluorfen.

Authors:  Hazel R Corradi; Anne V Corrigall; Ester Boix; C Gopi Mohan; Edward D Sturrock; Peter N Meissner; K Ravi Acharya
Journal:  J Biol Chem       Date:  2006-10-17       Impact factor: 5.157

Review 2.  Homozygous variegate porphyria: an evolving clinical syndrome.

Authors:  R J Hift; P N Meissner; G Todd; P Kirby; D Bilsland; P Collins; J Ferguson; M R Moore
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

3.  Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria.

Authors:  P Meissner; P Adams; R Kirsch
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

4.  Quantitative structural insight into human variegate porphyria disease.

Authors:  Baifan Wang; Xin Wen; Xiaohong Qin; Zhifang Wang; Ying Tan; Yuequan Shen; Zhen Xi
Journal:  J Biol Chem       Date:  2013-03-06       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.